Industry Background:
Increased Prevalence of Neurological Disorders Like Alzheimer’s disease, The Rise in Geriatric Population and Rapid Advancements in Medical Science are the key factors driving the global brain implant market. Brain implants are the neural implants that directly connected to the brain. These implants electrically stimulate, block or record the signals from the brain. It enables communication between the brain and electronic devices, thus permitting brain activity to be modified, recorded or translated. The purpose of these implants is establishing a biomedical prosthesis circumventing areas in the brain that have become dysfunctional after a stroke or other head injuries. However, the High Cost of Implant Installation may hinder the market growth.This growth is primarily driven by Increased Prevalence of Neurological Disorders Like Alzheimer’s disease
.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Forecast Period | 2022-2027 |
Volume Unit | K Units |
Value Unit | USD (Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
The Health Care Equipment sector in the
region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Boston Scientific Corporation (United States), St Jude Medical (United States), Medtronic (Ireland), Pixium Vision (France), Neuralink (United States), Aleva Neurotherapeutics SA (Switzerland), Nevro Corporation (United States), NeuroPace Inc. (United States), NDI Medical LLC (United States) and Thermo Fisher Scientific Inc. (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
On 24th January 2019, Boston Scientific Corporation has launched the Vercise Primary Cell and Vercise Gevia, Deep Brain Stimulations (DBS) with directional leads. These new systems are approved by the United States Food and Drug Administration (FDA). These systems designed to allow physicians to control the range, shape, position and direction of electrical stimulation to treat symptoms of Parkinson’s disease.
Influencing Trend:
Use of Robotic Assistance for Brain Transplant Surgery
Market Growth Drivers:
Increased Prevalence of Neurological Disorders Like Alzheimer’s disease, The Rise in Geriatric Population and Rapid Advancements in Medical Science
Challenges:
Brain Implants are Vulnerable to Cyber Attacks and Legal Issues and Regulations
Restraints:
Unavailability of Treatment and High Cost of the Implant Installation
Opportunities:
Increasing Healthcare Awareness and Technological Advancement, Growth in the Healthcare Sector and Increased Research and Development Activities
AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.
Data Sources of Brain Implants Market Study
Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Brain Implants Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.
The primary interviews and data collected as per the below protocols:
By Designation: C-Level, D-Level, Others
By Company Type: Tier 1, Tier 2, Tier 3
Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Brain Implants players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.
Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Brain Implants Study Sheds Light on
The Brain Implants Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Brain Implants industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Brain Implants industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.